11/17/2021 1:12:24 AM
Under Merck KGaA Terms, Imugene Will Be Sponsor Of Study And To Fund Clinical Study From Existing Budgets And Resources
11/17/2021 1:10:17 AM
Imugene Reports Clinical Trial Supply Deal With Merck KGaA, Pfizer To Evaluate HER-Vaxx With Avelumab For Gastric Cancer
11/11/2021 1:02:38 AM
Merck KGaA Q3 Group Net Sales Rise By 11.8% To EUR 5.0 Bln
9/22/2021 10:08:04 AM
Merck KGaA Appoints Sabia Schwarzer As Head Of Group Communications, Brand And Corporate Affairs, Effective January 2022
9/21/2021 9:08:08 AM
Nektar Collaborates With Merck KGaA And Pfizer To Combine NKTR-255 With Avelumab In JAVELIN Bladder Medley Study
9/20/2021 3:20:11 AM
Merck KGaA To Invest More Than EUR 3 Bln In Electronics Business Sector Over The Next 5 Years
9/16/2021 1:33:21 AM
BIOCORP, MERCK Agree For Development Of Specific Version Of Mallya Device In The Field Of HGH
9/9/2021 3:24:08 AM
Merck KGaA Expects Group Sales Of Around EUR 25 Bln In 2025
8/5/2021 1:02:35 AM
Merck KGaA Q2 Group Net Reported Sales Up 18.2% To EUR 4.9 Bln
6/10/2021 4:07:14 AM
Merck KGaA Secures Halal Certifications For Cosmetics Effect And Care Solutions Portfolio